Abbott Diagnostics Technologies AS NycoCard™ CRP test - HSA Registration DE0011567
Access comprehensive regulatory information for Abbott Diagnostics Technologies AS NycoCard™ CRP test in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0011567 and owned by Abbott Diagnostics Technologies AS. The device was registered on November 08, 2012.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
NycoCard™ CRP Test is an in vitro diagnostic test for the quantitative determination of C-reactive protein(CRP) in human whole blood and in human serum and plasma. The measurement of CRP provides information for the detection and evaluation of infection, tissue injury, inflammatory disorders and associated diseases.

